My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 121

    1.

    Hitting bacteria at the heart of the central dogma: sequence-specific inhibition.

    Rasmussen LC, Sperling-Petersen HU, Mortensen KK.

    Microb Cell Fact. 2007 Aug 10;6:24.PMID: 17692125 [PubMed - in process]Related articlesFree article

    2.

    Neutrally charged phosphorodiamidate morpholino antisense oligomers: uptake, efficacy and pharmacokinetics.

    Arora V, Devi GR, Iversen PL.

    Curr Pharm Biotechnol. 2004 Oct;5(5):431-9.PMID: 15544491 [PubMed - indexed for MEDLINE]Related articles

    3.

    Peptide nucleic acids (PNAs) antisense effect to bacterial growth and their application potentiality in biotechnology.

    Hatamoto M, Ohashi A, Imachi H.

    Appl Microbiol Biotechnol. 2010 Mar;86(2):397-402. Epub 2010 Feb 5.PMID: 20135118 [PubMed - in process]Related articles

    4.

    Antisense treatments for biothreat agents.

    Warfield KL, Panchal RG, Aman MJ, Bavari S.

    Curr Opin Mol Ther. 2006 Apr;8(2):93-103. Review.PMID: 16610760 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers.

    Amantana A, Iversen PL.

    Curr Opin Pharmacol. 2005 Oct;5(5):550-5. Review.PMID: 16087398 [PubMed - indexed for MEDLINE]Related articles

    6.

    Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids.

    Nekhotiaeva N, Awasthi SK, Nielsen PE, Good L.

    Mol Ther. 2004 Oct;10(4):652-9.PMID: 15451449 [PubMed - indexed for MEDLINE]Related articles

    7.

    Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.

    Nelson MH, Stein DA, Kroeker AD, Hatlevig SA, Iversen PL, Moulton HM.

    Bioconjug Chem. 2005 Jul-Aug;16(4):959-66.PMID: 16029037 [PubMed - indexed for MEDLINE]Related articles

    8.

    True antisense oligonucleotides with modified nucleotides restricted in the N-conformation.

    Koizumi M.

    Curr Top Med Chem. 2007;7(7):661-5. Review.PMID: 17430207 [PubMed - indexed for MEDLINE]Related articles

    9.

    RNA interference-based therapeutics: new strategies to fight infectious disease.

    López-Fraga M, Wright N, Jiménez A.

    Infect Disord Drug Targets. 2008 Dec;8(4):262-73. Review.PMID: 19075801 [PubMed - indexed for MEDLINE]Related articles

    10.

    Antisense strategies in degenerative joint diseases: sense or nonsense?

    Huber LC, Distler O, Gay RE, Gay S.

    Adv Drug Deliv Rev. 2006 May 20;58(2):285-99. Epub 2006 Feb 14. Review.PMID: 16574269 [PubMed - indexed for MEDLINE]Related articles

    11.

    Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection.

    Swenson DL, Warfield KL, Warren TK, Lovejoy C, Hassinger JN, Ruthel G, Blouch RE, Moulton HM, Weller DD, Iversen PL, Bavari S.

    Antimicrob Agents Chemother. 2009 May;53(5):2089-99. Epub 2009 Feb 17.PMID: 19223614 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Nucleic acids-based therapeutics in the battle against pathogenic viruses.

    Haasnoot J, Berkhout B.

    Handb Exp Pharmacol. 2009;(189):243-63. Review.PMID: 19048203 [PubMed - indexed for MEDLINE]Related articles

    13.

    Progress in the development of nucleic acid therapeutics.

    Kalota A, Dondeti VR, Gewirtz AM.

    Handb Exp Pharmacol. 2006;(173):173-96. Review.PMID: 16594616 [PubMed - indexed for MEDLINE]Related articles

    14.

    Phosphorodiamidate morpholino oligomers: favorable properties for sequence-specific gene inactivation.

    Iversen PL.

    Curr Opin Mol Ther. 2001 Jun;3(3):235-8. Review.PMID: 11497346 [PubMed - indexed for MEDLINE]Related articles

    15.

    Fine tuning of electrostatics around the internucleotidic phosphate through incorporation of modified 2',4'-carbocyclic-LNAs and -ENAs leads to significant modulation of antisense properties.

    Zhou C, Liu Y, Andaloussi M, Badgujar N, Plashkevych O, Chattopadhyaya J.

    J Org Chem. 2009 Jan 2;74(1):118-34.PMID: 19055352 [PubMed - indexed for MEDLINE]Related articles

    16.

    Antisense RNA based down-regulation of RNaseE in E. coli.

    Kemmer C, Neubauer P.

    Microb Cell Fact. 2006 Dec 12;5:38.PMID: 17164000 [PubMed]Related articlesFree article

    17.

    Prospects for antisense agents in the therapy of bacterial infections.

    Chopra I.

    Expert Opin Investig Drugs. 1999 Aug;8(8):1203-8.PMID: 15992145 [PubMed]Related articles

    18.

    Antisense oligonucleotides in cancer: recent advances.

    Lebedeva IV, Stein CA.

    BioDrugs. 2000 Mar;13(3):195-216.PMID: 18034525 [PubMed - in process]Related articles

    19.

    Antisense DNA and RNA agents against picornaviruses.

    Lim T, Yuan J, Zhang HM, Sall A, Liu Z, Su Y, Yang D.

    Front Biosci. 2008 May 1;13:4707-25. Review.PMID: 18508540 [PubMed - indexed for MEDLINE]Related articles

    20.

    Advantages of antisense drugs for the treatment of oral diseases.

    Nedbal W, Teichmann B.

    Antisense Nucleic Acid Drug Dev. 2002 Jun;12(3):183-91. Review.PMID: 12162701 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk